Gordon et al. demonstrated that, by blocking PD-1/PD-L1 interaction with antibodies, the phagocytic potency of macrophages increased in vivo, thus reducing tumor growth in a cancer mouse model [19]. The gene discussed is PDCD1; the disease is cancer.